Liver Cirrhoses clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
open to eligible people ages 18 years and up
This study compares gadolinium contrast-enhanced Abbreviated MRI (AMRI) to standard ultrasound for Hepatocellular Carcinoma (HCC) screening and surveillance in subjects with liver cirrhosis.
at UCSD
Our lead scientists for Liver Cirrhoses research studies include Claude B Sirlin, MD.
Last updated: